Profile for Poland Patent: 3290414
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Poland Patent: 3290414
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | May 22, 2033 | Genentech Inc | ROZLYTREK | entrectinib |
| ⤷ Start Trial | May 22, 2033 | Genentech Inc | ROZLYTREK | entrectinib |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
